| Kim Barry, MS, AT | |
|
200 Woodland St, Oberlin, OH 44074-1051 | |
| (440) 775-8589 | |
| Not Available |
| Full Name | Kim Barry |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Sports Medicine |
| Location | 200 Woodland St, Oberlin, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952710295 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083S0010X | Preventive Medicine - Sports Medicine | 003905 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kim Barry, MS, AT 200 Woodland St, Oberlin, OH 44074-1051 Ph: (440) 775-8589 | Kim Barry, MS, AT 200 Woodland St, Oberlin, OH 44074-1051 Ph: (440) 775-8589 |
News Archive
Neurodegenerative disorders such as Alzheimer's disease are typically characterized by protein deposits in the brain. These are comprised of defective, insoluble proteins which no longer fulfill their function and which cells are unable to break down. The work group headed by Professor Christian Behl of the Institute of Pathobiochemistry of the University Medical Center of Johannes Gutenberg University Mainz has determined the RAB3GAP complex as a novel factor that influences the efficient degradation of proteins.
Australian researchers have called for additional services for survivors of intimate partner violence - warning those who have these experiences are more vulnerable to elder abuse.
Arlington Medical Resources, a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that electrical cardioversion usage patterns in Europe differed dramatically by country in the fourth quarter of 2009. While ECV represented almost half of all cardioversion attempts in Germany, in Spain ECV accounted for only 13% of cardioversion attempts.
Researchers at the University of California, San Diego School of Medicine have developed a new way to parse and understand how special proteins called "master regulators" read the genome, and consequently turn genes on and off.
DiaGenic: Important milestones achieved. DiaGenic's collaboration with Pfizer is the first collaboration between a diagnostics company and the market leader for Alzheimer's therapeutics that aims to identify blood based diagnostic tools that can detect early Alzheimer's disease, before the disease is clinically overt, or accessible to other either more invasive and costly or less precise diagnostic exploration.
› Verified 9 days ago